A detailed history of 44 Wealth Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, 44 Wealth Management LLC holds 12,340 shares of AZN stock, worth $817,525. This represents 0.34% of its overall portfolio holdings.

Number of Shares
12,340
Previous 12,736 3.11%
Holding current value
$817,525
Previous $911,000 5.49%
% of portfolio
0.34%
Previous 0.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$76.67 - $87.62 $30,361 - $34,697
-396 Reduced 3.11%
12,340 $961,000
Q2 2023

Jul 18, 2023

SELL
$69.91 - $75.81 $106,333 - $115,307
-1,521 Reduced 10.67%
12,736 $911,000
Q1 2023

Apr 20, 2023

SELL
$63.15 - $71.6 $280,070 - $317,546
-4,435 Reduced 23.73%
14,257 $989,000
Q4 2022

Jan 20, 2023

BUY
$54.21 - $70.44 $12,414 - $16,130
229 Added 1.24%
18,692 $0
Q3 2022

Oct 12, 2022

SELL
$53.02 - $135.75 $43,688 - $111,858
-824 Reduced 4.27%
18,463 $1.01 Million
Q2 2022

Jul 22, 2022

BUY
$59.26 - $71.14 $30,163 - $36,210
509 Added 2.71%
19,287 $1.27 Million
Q1 2022

Apr 18, 2022

BUY
$55.72 - $67.12 $12,759 - $15,370
229 Added 1.23%
18,778 $1.25 Million
Q4 2021

Jan 13, 2022

SELL
$54.02 - $63.83 $15,773 - $18,638
-292 Reduced 1.55%
18,549 $1.08 Million
Q3 2021

Oct 20, 2021

SELL
$55.56 - $60.79 $10,611 - $11,610
-191 Reduced 1.0%
18,841 $1.13 Million
Q2 2021

Jul 19, 2021

BUY
$48.42 - $60.18 $215,565 - $267,921
4,452 Added 30.53%
19,032 $1.14 Million
Q1 2021

May 18, 2021

BUY
$47.16 - $54.44 $235,658 - $272,036
4,997 Added 52.14%
14,580 $725,000
Q4 2020

Mar 05, 2021

BUY
$48.52 - $58.02 $464,967 - $556,005
9,583 New
9,583 $479,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track 44 Wealth Management LLC Portfolio

Follow 44 Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 44 Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 44 Wealth Management LLC with notifications on news.